Abstract
Recent research developments in the field of NO-donor compounds have concerned conjugation of NO-donor moieties with antioxidant groups, NO-donor targeting, design of NO-donor hybrid drugs and of NOdelivery systems. These new approaches are illustrated and discussed through selected examples.
Keywords: nitric oxide, no-donors, no-donor antioxidants, no-donor targeting, drug/no-donor hybrids, no-delivery systems